Skip to content
Medperion

Medperion

Healthcare·Germany·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Medperion?

Medperion is currently owned by Findos Investor through Findos Investor Fund III (2017 vintage), since 2018.

Hand-verified · updated 2026-07-17

Findos Investor
Investor
Findos Investor
Findos Investor Fund III · 2017 · Small-Mid Buyout

Key facts

HQGermany
SectorHealthcare
StatusActive
Track Medperion

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

About Medperion

Medperion is a Cologne-based healthcare services group that provides integrated medical, marketing, sales and communication solutions to pharmaceutical and healthcare companies across the German-speaking DACH region of Germany, Austria and Switzerland. Built around brands including Careforce, Sanvartis, MCG Medical Consulting Group, Brandpepper and A&O Gesundheit, the group spans contract sales organisation field teams, telesales and medical hotlines, patient support and nurse programmes, and brand, PR and omnichannel campaign work across a product's lifecycle. According to its own disclosures, Medperion employs more than 1,200 experts across five offices and draws on over 25 years of industry experience, positioning itself as one of the leading communications and sales service providers to the pharmaceutical industry in German-speaking markets.

Ownership journey

The group traces its origins to Careforce, founded in 2000 by Marko-Rene and Andrea Scholl as a personnel and sales services specialist for the pharmaceutical and wider healthcare market. In 2018 the Munich-based mid-market private equity firm Findos Investor backed the business through its Findos Investor Fund III, with Careforce acquiring the Duisburg healthcare call-centre operator Sanvartis to form Careforce Sanvartis Holding, alongside the Careforce founders and Sanvartis managers Manuel Ebner, Jan Hermann and Andreas Bleiziffer as co-shareholders. Findos Investor Fund III remains an active shareholder and the group is still listed as a current holding; no exit or secondary transaction has been recorded.

Under PE ownership

Since the 2018 investment the group has pursued a buy-and-build strategy, consolidating a fragmented set of healthcare services specialists into a single platform. It added the Vendus Group in 2020, consolidated its brands under the Medperion name in 2022, and acquired Eigler Communication in 2024, extending its reach from field sales and call-centre operations into medical content, brand strategy and omnichannel marketing. The combined group now spans medical, marketing and sales pillars under leadership including chief executive Kai Tobien and chief financial officer Heiko Hickstein, and has signalled international expansion beyond its DACH base from 2025. This growth has taken Medperion to more than 1,200 employees across five offices in Germany, Austria and Switzerland, per company disclosures.

Get the full record on Medperion.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue